Wockhardt Limited
WOCKPHARMA
Peringkat dalam Saham
#4670
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Harga Saham
$19.63
Kapitalisasi Pasar
$3.19B
Perubahan (1 hari)
-5.40%
Perubahan (1 tahun)
25.85%
Negara
IN
Perdagangan Wockhardt Limited (WOCKPHARMA)
Kategori
Healthcare
Riwayat harga saham Wockhardt Limited (WOCKPHARMA)
Harga penutupan tertinggi: $21.97 pada 2026-10-01
Harga penutupan terendah: $5.42 pada 2000-02-01
Harga penutupan terendah: $5.42 pada 2000-02-01
Riwayat harga saham Wockhardt Limited dari 2000 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 16.12% |
| 2025 | -8.59% |
| 2024 | 260.79% |
| 2023 | 69.56% |
| 2022 | -45.77% |
| 2021 | -17.40% |
| 2020 | 94.38% |
| 2019 | -52.30% |
| 2018 | -40.76% |
| 2017 | 21.94% |
| 2016 | -58.62% |
| 2015 | 54.74% |
| 2014 | 138.08% |
| 2013 | -77.77% |
| 2012 | 352.82% |
| 2011 | -17.27% |
| 2010 | 111.82% |
| 2009 | 75.19% |
| 2008 | -79.38% |
| 2007 | 30.35% |
| 2006 | -18.10% |
| 2005 | 21.47% |
| 2004 | 52.62% |
| 2003 | 71.77% |
| 2002 | -10.48% |
| 2001 | 12.71% |
| 2000 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $63.28 | 71.77% |
US
|
|
| $45.86 | 36.56% |
SE
|
|
| $172.94 | 25.05% |
FR
|
|
| $112.94 | 53.35% |
US
|
|
| $59.52 | -0.48% |
IT
|
